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The Dispersal of Mucosal Memory B Cells:
Evidence from Persistent EBV Infection
tion includes memory B cells (Liu et al., 1988). There is
also evidence that cells, equivalent to those of the rodent
splenic marginal zone, are present in human splenic
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We have previously raised the possibility that the hu-Summary
man herpesvirus Epstein-Barr virus (EBV) may be a
marker for memory B cells (Khan et al., 1996). This isWe have used latent infection with the human her-
because EBV infection in the peripheral blood of healthypesvirus Epstein-Barr virus to track the dispersal of
carriers is tightly restricted to memory B cells (less thanmemory B cells from the mucosal lymphoid tissue of
1 in 1000 infected cells are naive) (Babcock et al., 1998;Waldeyer’s ring (tonsils/adenoids). EBV is evenly dis-
Joseph et al., 2000b). These cells are latently infectedtributed between the memory compartments of Wal-
but express virtually no viral genetic information asdeyer’s ring and the peripheral blood. However, it has
judged by RT-PCR (Qu and Rowe, 1992; Tierney et al.,an approximately 20-fold higher preference for Wal-
1994; Chen et al., 1995; Babcock et al., 1999). We havedeyer’s ring over the spleen or mesenteric lymph
suggested that they constitute a critical site of EBVnodes. These observations are consistent with a
persistence because immunological memory survivesmodel whereby the virus preferentially establishes
for the life time of the host, as does EBV. Furthermore,persistent infection within memory B cells from Wal-
because viral proteins are not expressed, the cells can-deyer’s ring. The virus then colonizes the entire periph-
not be destroyed by the immune system. However, theeral lymphoid system, at a low level, by trafficking with
lack of viral proteins also makes them nonpathogenic,these memory B cells as they circulate through the
i.e., not a threat to the host.body and back to Waldeyer’s ring. This pathway may
If peripheral memory cells are an important site ofreflect that of normal memory B cells derived from
viral persistence, they must arise from the original sitenasopharyngeal and other mucosal lymph nodes.
of infection, the mucosal lymphoid tissue of Waldeyer’s
ring, which is composed of the tonsil and adenoidsIntroduction
(Perry and Whyte, 1998). Ultimately, these cells should
also be capable of trafficking the virus back to Waldey-Memory is a defining property of the immune system.
er’s ring since the virus replicates there (Babcock et al.,The humoral arm, antibody production, of the immune
1998). This virus is either shed into saliva to infect newresponse is performed by B lymphocytes. Virgin B cells
hosts or infects more B cells, which we have proposedare produced in the bone marrow and migrate to the
will ultimately become circulating memory cells. We
secondary lymphoid tissue where they either receive
have developed a model of how tonsillar B cells, latently
rescue signals or die (MacLennan, 1998). The resulting
infected with EBV, become memory cells (the details of
naive B cells recirculate through the secondary this model have been described elsewhere [Thorley-
lymphoid tissue until they encounter cognate antigen. Lawson and Babcock, 1999; Thorley-Lawson, 2001]).
In response to the antigen and with help from T helper This process involves the differential expression of viral
(Th) cells, the naive B cells become activated, migrate latent proteins that provide, sequentially, activation and
into the follicles, and expand to form a germinal center then survival/rescue signals. An alternate scenario,
where the immunoglobulin genes undergo isotype whereby EBV directly infects memory B cells, which
switching and affinity maturation (MacLennan, 1994; Liu then clonally expand and then become resting, has also
and Arpin, 1997). Eventually, again with the help of anti- been suggested (Kurth et al., 2000). In either case, it is
gen and Th cells, the germinal center cells exit the cell our assumption that once EBV has gained access to
cycle and mature into memory cells (Arpin et al., 1995). the memory compartment the cells are maintained as
The ability of mature B lymphocytes to recirculate was normal memory B cells because of their lack of viral
first established in rats (Howard et al., 1972; Nieuwen- gene expression. Thus, latent EBV would be expected
huis and Ford, 1976). However, it was subsequently to track with normal memory cells without affecting their
shown, also in the rat, that a subset of B cells, character- behavior.
ized by those resident in the marginal zone of the spleen, We assume that memory cells, latently infected with
is comparatively sessile (Gray et al., 1982). This popula- EBV, arise from Waldeyer’s ring and that they behave,
biologically, as normal memory B cells. If true, then there
are two obvious scenarios to explain the presence of3 Correspondence: david.thorley-lawson@tufts.edu
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infected memory cells in the peripheral blood. The most previously developed and characterized in detail. This
method combines DNA PCR and limiting dilution analy-intriguing explanation, which may also shed light on the
sis to derive precise frequencies of virus-infected cellsmigratory behavior of normal memory B cells, is that
in a given population (see Khan et al., 1996 and Experi-memory cells from Waldeyer’s ring enter the peripheral
mental Procedures for details).circulation and return preferentially back to Waldeyer’s
The estimated frequencies of EBV-infected cells inring. This would explain the presence of memory B cells
the B cell compartment of 43 tonsils, 18 spleens, andin the blood (Klein et al., 1994, 1998) and would allow the
14 MLNs from different donors are summarized in Tablesmemory cells and EBV to access the whole B lymphoid
1 and 2. It was not possible to obtain multiple lymphoidsystem. In this case, the virus would be found preferen-
organs from the same human donors. To look for signifi-tially in the blood and Waldeyer’s ring but would also be
cant differences among the populations, we have takendetectable throughout the secondary lymphoid system
a statistical approach. Differences in the level of infec-albeit at a reduced level.
tion were striking. In approximately one-third of theOn the other hand, memory cells, whether latently
spleen and MLN samples, we were unable to detect anyinfected or not, from Waldeyer’s ring may not enter the
EBV-infected cells in the 107 B cells tested, the cutoffperipheral circulation but remain resident in the marginal
point for the assay. This was unexpected since all ofzone. If true, then the latently infected memory cells,
these donors were identified as serologically EBV posi-critical to viral persistence and reactivation, would effec-
tive. Furthermore, one-third EBV negative would be ex-tively be restricted to Waldeyer’s ring, and those in the
tremely high for a random adult population. In our stud-blood would represent a dead end for the virus. Such
ies on healthy adults, we find approximately 5% to becells may arise as an epiphenomenon of viremia during
EBV negative by DNA PCR, which is in good agreementacute infection. In this model it would be expected that
with previously published estimates based on serologi-memory cells latently infected with EBV would be most
cal approaches (Rickinson and Kieff, 2001). In addition,prevalent in the lymphoid tissue of Waldeyer’s ring. It
for those cases where the virus could be detected, themight also be expected that the levels of infected cells
levels of infected cells were much lower in the spleenin the peripheral blood would decay over time; however,
and MLN than in the tonsil samples.this is not so since the numbers appear to be extremely
We have shown previously that the distribution of fre-stable for many years (Khan et al., 1996 and our unpub-
quencies of infected cells in the peripheral blood oflished data).
an adult population is skewed, but the natural log (ln)A third possibility is that the dispersal of EBV-infected
derivatives of the frequencies approximates a normalmemory cells may not be subject to the restrictions that
distribution (Khan et al., 1996). Figure 1A compares themay apply to uninfected memory cells. This is unlikely
frequencies of infected cells in the unfractionated B cellsince there are no known viral genes expressed in the
population from the tonsils with those from the spleeninfected cells that could affect their behavior. Neverthe-
and MLN samples where the virus could be measured.less, in this scenario EBV would be expected to colonize
The frequencies of virus-infected B cells are significantlythe whole lymphoid system, without specificity for a
lower for the spleen and MLN than for the tonsil samples.particular organ.
The means derived from the ln frequencies for the threeTo distinguish these possibilities, we have studied the
sites were 73/107 for tonsil, 12/107 for spleen, and 14/distribution of EBV-infected cells in five locations: the
107 for MLN (Table 2). This indicates a highly significantpalatine tonsil and adenoids—major components of
difference of about 5- to 6-fold in the levels of virus-Waldeyer’s ring—together with spleen, mesenteric
infected cells in spleen (p  0.002) and MLN (p  0.009)lymph node (MLN), and the peripheral blood. It is our
compared to the tonsil. This calculation does not trulyassumption that EBV will act as a marker for memory
demonstrate the differences, however, because it doescells that originate in the mucosal lymphoid tissue of
not take into account the one-third of the spleen and
Waldeyer’s ring. Our results demonstrate that the virus-
MLN samples with the lowest frequencies, i.e., where
infected cells are distributed evenly throughout the
the virus was undetected (frequency 1/107). There are
memory compartments of the tonsil, adenoids, and pe- two ways to correct for this, and both yield similar re-
ripheral blood and show a high degree of preference for sults. First, we could compare frequencies by also ignor-
the tonsil over the spleen or MLN. We propose, there- ing the lowest one-third of tonsil samples. Alternatively,
fore, that EBV preferentially persists in B cells derived we could make a conservative estimate of the level of
from the mucosal lymphoid tissue of Waldeyer’s ring, infection in the spleen and MLN samples where the virus
that the presence of such latently infected cells in the was undetected. Since we can detect one infected cell
blood implies that these mucosal memory cells do circu- in 107 uninfected cells, we can be reasonably sure that
late, and that these cells occasionally enter nonmucosal a value of 0.5/107 will be an overestimate for all these
secondary lymphoid tissue such as the spleen. samples. By assigning this value to the undetectable
samples, we can calculate a more accurate estimate
Results of the relative frequencies of virus-infected cells in the
spleen and MLN populations. In this case, the mean
EBV-Infected Cells Are Rare in Spleen and Mesenteric frequencies were 4/107 for spleen and 6/107 for MLN
Lymph Nodes Compared to the Tonsil (Table 2). This analysis indicates that the frequencies of
To assess the prevalence of EBV-infected cells in virus-infected cells is closer to 20-fold lower in the
lymphoid tissue, we have studied multiple samples of spleen (p 0.001) and 10-fold lower (p  0.001) in the
tonsil, spleen, and mesenteric lymph nodes. To measure MLN compared to the tonsil.
One possible explanation for this result was thatthe levels of infection, we used a technique that we have
Tissue Tropism of EBV
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Table 1. Frequencies/107 of EBV-Infected B Cells in Spleen, Mesenteric Lymph Node, Tonsil, and Peripheral Blood
Spleen MLN Tonsil Peripheral Blood
Whole IgD IgD Whole Whole IgD IgD Mem. GC Whole IgD
200 220 1250 222 2850 300 2550
125 75 200 180 1050 200 2335 250 2095
65 13 100 100 760 300 1800 2000 1000 154 1250
20 8 18 19 900 270a 1200 1000a 300a 125 1170
15 9 625 150 1200 112 850
14 7 12 9 670 100 1200 100 740
14 1 5 8 1000 1000 1000 100 600
6 1 7 3 480 300 800 215 1500 85 530
3 1 3 2 300 30 670 85 470
2 1 1 1 430 50 600 530 140 66 450
2 1 1 1 360 280 600 56 440
1 1 1 1 290 200 465 50 390
1 1 250 200 333 420 230 43 360
1 1 205 70 330 40 280
1 180 100 280 40 260
1 195 150 240 33 220
1 180 75 240 32 190
1 200 200 200 90 285 30 190
160 25 200 30 180
130 75a 200 100a 40a 30 145
120 20 180 26 140
95 40 180 25 110
90 25 150 25 33
70 40 100 19 30
90 100 80 6 20
33 10 80 3 15
38 15 60 3 6
33 15 56 3 3
40 25 50 3 3
38 25 50
26 2 50
55 50a 35 25a 70a
23 15 30
13 1 25
10 1 20
5 1 20
15 20 10
4 1 10
3 1 6
4 4 4
2 1 4
1 1 1
3 4 1
For details of the purification protocols and purity for the different populations, see the Experimental Procedures section.
a The data from these three tonsil separations have been published previously (Babcock et al., 2000).
something in the spleen and MLN samples was inhibi- far more prevalent in the tonsil than in the spleen or
MLN.tory for the DNA PCR. To test this, spleen samples with
low or undetectable frequencies were reanalyzed with
or without cells from the EBV-positive cell line IB4 added EBV-Infected Cells Are Equally Distributed In the IgD
at a frequency of 1/105, approximately the mean fre- Compartments of the Blood and Tonsil
quency of infection found in the tonsil samples. In all EBV is restricted to the memory (IgD, CD27, sIg,
cases tested, the IB4 cells were readily detected at the CD20) subset in the peripheral blood (Joseph et al.,
expected frequency. For example, in one such analysis 2000b) and is also found in memory cells in the tonsil
only one EBV-positive cell was found in a total of 107 (Babcock and Thorley-Lawson, 2000). To understand
spleen B cells analyzed. However, when the IB4 cells how EBV persists, it is important to know if the virus
were added to the same spleen B cell population prior localizes preferentially to the periphery or the tonsil. To
to the analysis, a frequency of 1.3 infected cells/105 total test this, we have analyzed the frequencies of virus-
spleen B cells was observed, close to the expected infected cells in IgD B cells from 43 tonsils and 29
value of 1/105 (data not shown). These controls exclude samples of peripheral blood. For the peripheral blood
the possibility that there was an artifact causing the low IgD, CD20 effectively defines memory cells, especially
estimates found with the spleen and MLN samples. as far as EBV latency is concerned. For the tonsil IgD,
CD20 defines a mixture of approximately equal num-We conclude, therefore, that EBV-infected cells are
Immunity
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Table 2. EBV-Infected Cells Are More Prevalent in the Tonsil Than
the Spleen or Mesenteric Lymph Node
# Samples Tested Mean (107)
Tonsil 43 73
Spleen (all)a 18 4
Spleen (measurable #1–12)b 12 12
Mesenteric lymph node (all)a 14 6
Mesenteric lymph node 10 14
(measurable #1–10)b
a Includes all samples from Table 1, assigning an arbitrary value of
0.5 for the samples with 1 infected cell/107 B cells tested.
b Excludes samples from Table 1 with values 1 infected cell/107 B
cells tested.
Tonsil versus spleen (#1–12), p  0.002 (t test).
Tonsil versus spleen (all), p  0.001 (t test), p  0.001 (Mann-
Whitney).
Tonsil versus MLN (#1–10), p  0.009 (t test).
Tonsil versus MLN (all), p  0.001 (t test), p  0.001 (Mann-
Whitney).
Spleen (#1–12) versus MLN (#1–10), p  0.8 (t test).
Spleen (all) versus MLN (all), p 0.7 (t test), p 0.75 (Mann-Whitney).
bers of memory and germinal center cells. Analysis of
eight tonsils (see below) revealed that the frequency
of virus-infected cells in the IgD fraction was closely
correlated with the level in the derived memory popula-
tion (R value of 0.94; p0.001); therefore, IgD CD20
is a good first approximation to the distribution of in-
fected cells in the tonsil memory compartment as well.
The data for IgD, CD20 cells from the tonsil and blood
Figure 1. Frequency Distribution of EBV-Infected Cells in Differentare presented in Tables 1 and 3, and the distribution of
Populations of B Cellsthe ln frequencies is demonstrated in Figure 1B. The
Whole B and memory B cells were purified as detailed in the Experi-mean and variance for the ln frequencies of the two
mental Procedures. The purified populations were costained for IgDpopulations were virtually identical (mean 4.7 and vari-
and the pan-B cell marker CD20 for reanalysis to check purity. The
ance 4.2 for the tonsil versus mean 5.2 and variance 3.4 frequencies of virus-infected cells were measured using limiting
for the blood). The actual means derived from the ln dilution DNA PCR analysis. In this technique, cell populations are
values were 110/107 for the tonsil and 175/107 for the serially diluted, and then multiple samples of each dilution are tested
for the presence of EBV with a DNA PCR assay that can detect aperipheral blood (p  0.33). It is apparent from these
single copy of the viral genome. By applying Poisson statistics, thestudies that, unlike the spleen and MLN, the virus-
absolute frequency of virus-infected cells can then be calculatedinfected cells are present at similar levels in the memory
(Khan et al., 1996). The actual frequencies are listed in Table 1; the
compartments of both the peripheral blood and the figure shows the distribution of the ln values of those frequencies.
tonsil. (A) Distribution of the ln frequencies of infected B cells in 107 unfrac-
tionated B cells from the tonsil, spleen, and MLN. Note that samples
of spleen (#  6) and MLN (#  4) with values of 1 infected B cellEBV-Infected Cells Are Equally Distributed
in 107 cells tested were not included.between Tonsils and Adenoids
(B) Distribution of the ln frequencies of infected cells in 107 memoryThe tonsils form part of a ring of lymphoid tissue in
cells from the peripheral blood or in 107 IgD cells from the tonsil.
the pharyngeal region. The entire structure is termed The mean and variance for ln values of the two populations were
Waldeyer’s ring and includes the lingual, palatine, and 4.7 and 4.2 for the tonsil and 5.2 and 3.4 for the blood.
tubal tonsils plus the adenoids (Perry and Whyte, 1998).
We have obtained paired samples of adenoids and pala-
tine tonsils from five donors and compared the frequen- 20-fold lower than in the tonsil but the levels in tonsil
and peripheral blood are similar. It is possible that thecies of EBV-infected cells in the bulk B cell populations
and in the fractionated IgD and IgD compartments. spleen contains no infected cells at all and that, when
EBV-infected cells were detected, they were derivedTable 4 shows that the frequencies of infected cells
were virtually identical for unfractionated B cells and for from infected cells in blood that contaminated the
spleen and MLN samples. EBV-infected cells from thetheir IgD and IgD compartments.
These studies show that EBV-infected cells are blood and tonsils can be distinguished from each other.
Latently infected memory cells are present in both, butequally distributed throughout Waldeyer’s ring.
only the tonsil contains B cells that are replicating the
virus for reinfection of naive B cells, which then expressThe State of Infected Cells in the Spleen Resembles
the Tonsil but Not the Peripheral Blood the viral growth-promoting genes (Babcock et al., 1998;
Joseph et al., 2000b). Consequently, EBV-infected naiveThe analysis described above demonstrates that the
level of EBV-infected cells in the spleen is approximately (IgD) B cells, viral replication, and the expression of
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were only able to detect expression of LMP1 (FigureTable 3. Distribution of EBV-Infected Cells among Tonsil Subsets
and Peripheral Blood Memory Cells 2C). This was found in both the IgD and IgDpopulation
of one spleen (#3). The failure to detect other latent# Samples
genes may be a consequence of the very low numbersTested Mean (107)
of infected cells and the possibility that the LMP1 RT-
Tonsil IgD 43 26
PCR may be the most sensitive latent gene RT-PCR.Tonsil IgD 43 110
This experiment indicates, however, that when latentPeripheral blood IgD (memory) 29 175
gene expression is observed in the spleen it does not
Tonsil IgD versus tonsil IgD, p  0.001 (paired samples t test). resemble the peripheral blood, where LMP1 expression
Tonsil IgD versus peripheral blood memory, p  0.33 (t test).
is never detected, but more closely resembles that seen
in the tonsil, where LMP1 is found in both infected IgD
and IgD populations.
latent genes involved in virus-driven growth, such as
Taken together, these results demonstrate that when
EBNA2 and LMP1, are all readily detectable in the tonsil
EBV-infected cells are present in the spleen they are
but are not expressed in the peripheral blood. For ten
not simply due to contaminating blood and that the
of the twelve spleen samples in which EBV DNA was
active process of infection, seen in the tonsil but not
detectable, we had sufficient material to perform cellular
the peripheral blood, is ongoing in the spleen albeit at
fractionation on the basis of IgD expression and to ana-
a much reduced level.
lyze the frequency of infected cells in the two popula-
tions. EBV-infected cells were found in the IgD com-
EBV-Infected Cells Are Underrepresented in the Naivepartment from the four spleen samples with the highest
Tonsillar B Cell Compartmentstarting levels of EBV infection (Table 1). The average
Our experiments demonstrate that EBV infection in theratio was approximately 1 IgD infected cell to 3.5 IgD
healthy carrier is preferentially found in the tonsil andinfected cells. This is similar to the ratio of 1:5.5, found
peripheral blood compared to other lymph nodes. Wein the tonsil (see below) and clearly different from the
have previously shown that EBV-infected cells may beperipheral blood where less than 1 in 1000 of the infected
found in all of the tonsil B cell subsets we have testedcells are IgD (Joseph et al., 2000b; see Table 5). In-
so far (Babcock et al., 2000; Joseph et al., 2000b). Tofected IgD cells were not found in the remaining spleen
further define the tropism of EBV in vivo, we looked tosamples. It was impossible to distinguish if this was
see if EBV was found preferentially in any of these sub-because infected IgD cells were only derived from con-
sets. The data for this analysis is listed in Table 1, andtaminating blood in these samples or the levels of in-
the analysis is summarized in Table 3. The tonsils werefected cells were simply too low to detect infected IgD
fractionated into IgD and IgD subsets, and the IgDcells.
subset further fractionated into memory and germinalOf the spleens tested only two had detectable EBV
center subsets based on expression of the germinalgene expression, and these were the two with the high-
center marker CD10. As mentioned earlier, the IgD frac-est levels of infected cells for which sufficient cells were
tion and the memory and germinal center subsets de-available for analysis. Lytic gene expression was readily
rived from it did not show striking differences in thedetected in both samples. An example of one is shown
eight samples analyzed; therefore, larger populationsin Figure 2B, demonstrating the expression of both im-
were not tested. We did observe striking differencesmediate early (BZLF1) and early (BHRF1) lytic genes.
between the IgD and IgD subsets, and therefore weThese same genes are expressed in the tonsil but not
accrued data from a large collection of samples to es-the peripheral blood. We also analyzed the cells for
tablish the significance of this difference. Altogether weexpression of the latent genes LMP1 and EBNA2, both
tested 43 EBV positive tonsils of which 35 had detect-of which are expressed in the tonsil (Babcock et al.,
able infected cells in both populations. Pairwise analysis2000) but not the peripheral blood (Qu and Rowe, 1992;
of these samples showed a high degree of correlationTierney et al., 1994; Chen et al., 1995; Babcock et al.,
with an R value of 0.763 (p  0.001), but the mean1999), and for LMP2, which is expressed in both. We
frequency (derived from the ln frequencies) of virus-
infected cells was 4-fold lower in the IgD population
compared to the IgD population (p0.001 in a pairedTable 4. Distribution of EBV-Infected Cells among Tonsil
samples t test) (Table 3). When the ratio of IgD to IgDand Adenoids from the Same Donor
infected cells was calculated for each tonsil and theFrequency/107 B cells
means of the ratios were derived, we found that the
Donor Population Tonsil Adenoid average ratio of IgD to IgD cells was approximately
1:5.5.1 Whole B 715 830
2 Whole B 6 8 This analysis suggests that virus-infected cells are
3 Whole B 43 32 evenly distributed throughout the IgD compartment of
IgD B 35 35 the palatine tonsil but that there is a significantly lower
IgD B 25 20
level of infected cells in the IgD compartment.4 Whole B 110 90
IgD B 100 65
IgD B 20 15 Discussion
5 Whole B 2300 1400
IgD B 4700 3500 In this paper we have shown that, in healthy carriers,
IgD B 560 590
EBV-infected cells reside at a level at least 20-fold higher
Immunity
750
Table 5. Infection in the Spleen Qualitatively Resembles the Tonsil but Not the Peripheral Blood
Ratio Infecteda Latent Genes Lytic Genes
Infected IgD IgD/IgD (LMP1) (BZLF1  BHRF1)
Tonsil Yes 1/5.5  
Spleen Yes 1/3.5  
Peripheral Blood No 1/1000b  
a The ratio was calculated for each pair; an average of all ratios was then estimated. The ratio was not calculated from the population means.
To perform the calculation, samples with IgD frequencies of 1/107 were excluded since this was the cutoff point of the assay.
b This number is derived from Joseph et al. (2000b).
in the tonsil and peripheral blood memory compartment for memory cells in the peripheral blood. This would
represent a dead end for the virus since the infectedcompared to the spleen and MLN. These results are
consistent with the idea that EBV does not indiscrimi- cells would not be able to return to Waldeyer’s ring to
reactivate and shed infectious virus into the saliva. Wenately colonize the entire B cell system but has evolved
primarily to colonize the lymphoid tissue of Waldeyer’s favor an alternative hypothesis, namely, that the virus
establishes latency in the memory cells of Waldeyer’sring. The question arises, therefore, as to what is the
significance of latently infected B cells in the blood and ring and uses these cells to traffic the virus throughout
the secondary lymphoid tissue, allowing the virus toperipheral lymph nodes. If memory cells remain in the
marginal zones of lymphoid tissues (Gray et al., 1982), colonize the entire B cell system. The latently infected
memory B cells would enter the peripheral circulationthen the simplest interpretation of our results is that
EBV has evolved to establish persistent infection in the and usually return to Waldeyer’s ring. Occasionally,
however, they could enter other secondary lymphoidresident memory cells of Waldeyer’s ring. However, at
some point, perhaps during acute infection, the virus or tissue. Here the virus could reactivate at some frequency
and in response to signals that remain unknown, justvirus-infected cells escape into the peripheral circula-
tion and establish persistent infections throughout the as in the tonsil. Infectious virus could then infect new
naive B cells that could differentiate into memory cellsB lymphoid system but for some reason with preference
Figure 2. RT-PCR Analysis for Viral Gene Expression in Splenic B Cells
(A) Flow cytometric analysis for the expression of IgD and the pan-B cell marker CD20 on whole spleen and purified IgD and IgD fractions
from the same spleen (similar analyses for peripheral blood and tonsil have been published previously [Babcock et al., 1998; Joseph et al.,
2000a]).
(B) Viral replication is ongoing in the spleen and tonsil but not in the peripheral blood. B cells were isolated as described in the Experimental
Procedures and assayed by RT-PCR for expression of the BZLF1 and BHRF1 genes. BZLF1 is the immediate early gene that initiates viral
replication and BHRF1 is expressed during the lytic cycle. , BJAB cells; , B95-8 cells.
(C) IgD and IgD B cells from a single spleen were analyzed for expression of the latent gene LMP1 by RT-PCR.
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to become resident in the marginal zone or enter the able to traffic to lymph nodes with preference for but not
circulation to return the virus to Waldeyer’s ring. This exclusively limited to Waldeyer’s ring, then this behavior
idea is supported by several observations. First, EBV is must also be a property of the B cells within which the
highly specific for memory cells in the peripheral circula- virus has established latent infection—memory B cells of
tion (Babcock et al., 1998; Joseph et al., 2000b). These the mucosal lymphoid tissue of Waldeyer’s ring. These
cells express few viral genes. In particular, the growth- considerations lead to the suggestion that EBV may be
promoting genes (e.g., EBNA2 and LMP1) are not ex- seen as a marker for the dispersal and trafficking of
pressed (Qu and Rowe, 1992; Tierney et al., 1994; Chen these memory B cells in the human. This would be analo-
et al., 1995; Babcock et al., 2000). This suggests that gous to studies with pseudorabies virus in which the
the virus has evolved a highly specific strategy to gain spread of the virus through the nervous system has been
access to long-lived resting memory B cells in the pe- used to map connections between neurons (DeFalco et
ripheral circulation as a nonpathogenic and immunologi- al., 2001).
cally invisible site of persistence. Second, we have ob- Little is known about the trafficking of memory B cells
served that EBV in the periphery is not restricted to latent in the human. Most splenic memory cells reside in the
infection in the blood but actually establishes infection in marginal zone (Liu et al., 1988; Dunn-Walters et al., 1995)
the spleen and MLN albeit at a lower level than in the and, in rats at least, these cells appear to be sessile
tonsil. The last piece of supporting evidence comes from (Gray et al., 1982). The exception, again shown in rats,
calculations of the numbers of infected B cells in the is when these cells migrate to the T cell zones of the
body. Despite the much higher frequencies of virus- spleen upon activation by antigen (Liu et al., 1991). The
infected cells in Waldeyer’s ring, compared to other crypt lymphoepithelium of the tonsil has been suggested
lymph nodes, approximately 90% of the total virus- as an analogous structure to the marginal zone of the
infected cells would still reside outside of Waldeyer’s spleen (Liu et al., 1995; Dono et al., 1996a, 1996b; Spen-
ring and the peripheral blood. This is because only2% cer et al., 1998). B cells in the tonsillar lymphoepithelium
of all B cells reside in these two locations. It seems have been shown to possess similar phenotypes to the
unlikely that EBV would have evolved to colonize the splenic marginal zone, including the presence of mem-
entire B cell system in such a way that 90% of the ory cells. Memory cells also circulate in the peripheral
infected cells were trapped in lymphoid tissue with no blood (Klein et al., 1994, 1998), but the relationship of
chance to return to Waldeyer’s ring. these cells to the marginal zone memory cells is not well
Previously we have estimated the total number of in- understood.
fected B cells in a healthy adult carrier based on the If our interpretation is correct, then these studies with
assumption that the frequency of infected cells in the EBV suggest that tonsillar memory B cells actually do
blood was representative of the whole lymphoid system. enter the peripheral circulation to the extent that an
It is now apparent that this assumption is incorrect and equilibrium is established where equal frequencies of
that the previous values overestimate the numbers of latently infected cells are found in the tonsil and periph-
cells. If we assume that the frequencies found in the eral blood memory compartments. How can this idea
spleen and MLN are representative of the whole be reconciled with the observation that marginal zone
lymphoid system, with the exception of the blood and B cells are comparatively sessile (Gray et al., 1982)? A
Waldeyer’s ring, and that there are approximately 5  trivial explanation could be that tonsillar memory cells
1011 B cells in an adult human, we can estimate that the in the human do not behave like rat spleen cells and
total number of infected cells ranges from 104–107 with are not sessile. Alternatively, the discrepancy could be
a mean of around 0.5  106. Only about 1% of these explained because there are at least ten times more
cells are latently infected memory cells in the peripheral memory B cells in Waldeyer’s ring than in the peripheral
circulation. Despite their small numbers, we believe that blood; therefore, at any given time greater than 10-fold
these cells are critical to viral persistence because they
more memory cells reside in the lymphoid tissue of Wal-
represent a stable pool of infected cells that are not
deyer’s ring compared to the blood. If this distribution
targets of immune surveillance and allow the virus to be
is representative of all Waldeyer’s ring-derived memorycontinuously trafficked through the peripheral lymphoid
cells and the rate of exchange between lymphoid tissuesystem.
and blood is low, then the discrepancy between abso-In vivo EBV has a very strong tropism for memory
lute numbers (10-fold more in Waldeyer’s ring than incells in the peripheral blood and for the lymphoid organs
blood) and frequency (equivalent in Waldeyer’s ring andof Waldeyer’s ring. This behavior stands in contrast to
blood IgD) may create the elusion of permanent resi-what is observed in vitro. EBV infects B cells in vitro
dency and explain previous studies suggesting thatwithout discrimination as to the type or origin of the B
these memory cells are resident. Still a third explanationcell (Nilsson, 1971), as long as the cell is resting (Aman
could be that memory cells are resident in the marginalet al., 1984; Thorley-Lawson and Mann, 1985). Since
zone and the cells in the blood may be produced throughthe virus is indiscriminate, the observed restriction to
the replication of these cells. This explanation would bememory cells in the blood must arise through the normal
consistent with the observation of Gray et al. (1982).biology of the B cells it infects. A similar argument can
Whatever the explanation, our studies on EBV providebe made for the apparent tropism for Waldeyer’s ring
a potential explanation for the origin of memory B cellssince the circulating memory cells express little or no
in the peripheral blood, namely, that they representviral genetic information. The only gene products de-
memory cells that leave secondary lymphoid tissue totected are LMP2a and possibly EBNA1. Neither of these
circulate throughout the B cell compartment. These maymolecules has the signaling capacity to affect the traf-
ficking properties of a memory B cell. If these cells are be the same cells as are found in the marginal zone
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Tonsils were obtained from patients undergoing routine tonsillec-or as represent a discrete subpopulation of circulating
tomies for obstructed breathing disorders at the Massachusettsmemory cells.
General Hospital. Discarded spleen and MLN tissue were obtainedThe trafficking pattern of normal memory B cells re-
through routine organ procurement procedures from stable, deiden-
vealed by the cells latently infected with EBV would be tified liver or kidney donors at the New England Medical Center
highly beneficial to the immune system since it would meeting usual organ donor medical suitability criteria. Lymphocyte
suspensions were prepared by mincing the tissues in PBSA (1allow memory B cells from one lymphoid organ to traffic,
PBS/0.5% BSA) to produce a crude suspension of lymphocytes andalbeit with a much lower efficiency, to other lymphoid
connective tissue. The suspension was passed through silkscreen totissues in the body. This would allow for immunosurveil-
remove any connective tissue. All tissues were stored in RPMI1640lance of the whole body for an infection that may have
medium at 4C until processing. Typically, the tissues were pro-
initially been localized to a specific area of the body. cessed within 2–6 hr of surgical removal. Control experiments indi-
It is our interpretation, therefore, that the apparent cated that no significant differences in cell viability, frequency of
infected cells, or viral gene expression were seen whether tissuestropism of EBV for peripheral blood memory cells and
were analyzed immediately (2 hr) or after overnight storage (16the preferential homing to Waldeyer’s ring represent
hr) at 4C. Heparinized peripheral blood was collected by venousproperties of the B cells that are infected and are not
puncture from healthy adult donors. Lymphocytes were purifiedspecific properties of the virus itself. An alternative inter-
from tissue suspensions or blood by Ficoll-Hypaque (Pharmacia)
pretation of our results is that the system is regulated centrifugation. The cells were washed two times with PBSA and
by cytotoxic T cells rather than normal B cell biology. resuspended at 2  107 cells/ml.
In this scenario, the tonsil would represent some form
of immunologically privileged site where the virus was Lymphocyte Fractionation—Whole B Cells
Magnetic bead (MACS or StemSep) separations and fluorescence-under less aggressive immunosurveillance. This would
activated cell sorting (FACS) on a MoFlo (Cytomation) were em-allow EBV replication, infection, lymphoblastoid trans-
ployed to purify whole B lymphocytes and B cell subsets. All theformation, and differentiation processes to occur at a
antibodies used were titrated for optimal recovery and purity ofmuch higher level than in other tissues, despite the fact
the desired population, and all separations and manipulations were
that cells both replicating the virus and undergoing performed at 4C. Whole B cells were isolated by MACS (Miltenyi
lymphoblastoid transformation express dominant epi- Biotec) using either biotinylated CD19 (our lab) and streptavidin
microbeads or a FITC-coupled anti-CD20 (pan-B cell marker) anti-topes recognized by CTL (Khanna et al., 1999; Tan et
body and anti-FITC microbeads. The details of the MACS-basedal., 1999). In this scenario, latent infection in the blood
protocol have been described previously (Babcock et al., 1998,would not represent unique access of infected memory
2000). A typical separation takes about 3 hr. The type of MACScells to the blood through differentiation; rather, it would
column used depended on the amount of cells expected in the
represent the consequence of highly aggressive CTL positive bound fraction. For an expected number less than 3  107
activity in the blood that eliminates all other infected total positive cells, the AS column was used, and for expected
numbers greater than 3  107 but less than 2  108 total positivecells due to the expression of CTL targets.
cells, the CS column was used. For spleen and MLN, whole B cellsIn the context of CTL surveillance, it is noteworthy that
were isolated by negative selection using the Stem Sep systemthe only B cell subset that expresses the lymphoblastoid
(Stem Cell Technologies, Vancouver, British Colombia, Canada).phenotype of the growth program, in which all of the
Lymphocytes were resuspended to 5  107 cells/ml in 1 PBS/
major latent CTL targets are present (Khanna et al., 2%FBS and incubated with 100 	l of the Human B Cell Enrichment
1999), are the naive B cells (IgD) of the tonsil (Joseph Cocktail (Stem Cell Technologies, Vancouver, British Colombia,
Canada) per ml of cells for 30 min. Sixty microliters of Step Sepet al., 2000a). This subset is also significantly underrep-
Magnetic Colloid was then added for each ml of cells, and theresented in numbers of infected cells compared to the
mixture was incubated for 30 min. During this incubation, the columnIgD subsets which express more restricted patterns
was assembled and primed with 3 column volumes of media. Forof latent genes. It is interesting to speculate that this
105–2  107 cells, a 0.1 in column was used; for 2–8  107 cells, a
underrepresentation may be a consequence of more 0.3 in column was used; for 5  107–3  108 cells, a 0.5 in column
aggressive CTL surveillance. was used; and for 108–1.5  109 cells, a 0.6 in column was used.
Samples were loaded onto the column and washed through with 3In conclusion, the current study indicates that EBV, a
column volumes of media.virus with no tropism for B cell subsets in vitro, has
tropism for the nasopharyngeal mucosal lymphoid tis-
Lymphocyte Fractionation—B Cell Subsetssue of Waldeyer’s ring in addition to its previously estab-
IgD and IgD B cells were separated either by MACS or FACS.lished tropism for memory B cells in the peripheral
For MACS the IgD and IgD subsets were isolated by sequentialblood. These studies raise the possibility that latent in-
positive selection with biotinylated anti-IgD and streptavidin mi-
fection by EBV may be a useful marker for tracking the crobeads followed by FITC-coupled anti-CD20 (pan-B cell marker)
dispersal and trafficking of memory cells derived from antibody and anti-FITC microbeads. The amounts of antibody added
were: 0.06 	g/ml of biotinylated anti-IgD antibody (Southern Bio-the nasopharyngeal lymphoid system. Specifically,
technology) and 1 	g/ml of FITC-coupled anti-CD20 (DAKO). Forthese cells may circulate in the periphery and enter other
FACS-based separations, buffy coat cells were stained with phy-lymphoid tissues but at a much lower (20-fold) level.
coerythrin (PE)-coupled anti-IgD (0.125 	g/ml) and FITC-coupled
anti-CD20 (0.5 	g/ml) (DAKO). All separations and manipulations
were performed at 4C.Experimental Procedures
Germinal center and memory B cells were isolated by FACS. First,
IgD B cells were purified using the MACS system by negativeCell and Tissue Preparation
BJAB is an EBV-negative B cell lymphoma cell line that was used selection for CD3 (to remove T cells) and IgD (to remove naive B
cells). The concentrations of biotinylated antibodies used were 60as a negative control for all experiments. IB4 (gift of Elliott Kieff) is
an EBV-positive lymphoblastoid cell line that contains approxi- 	g/ml of IgD antibody (Southern Biotechnology) and 30 	g/ml of
CD3 (Pharmingen). This fraction was then stained with PE-coupledmately four copies of the viral genome and was used as a positive
control for all experiments. B95-8 is an EBV-positive marmoset cell CD10 ([1:50] Pharmingen) and FITC-coupled IgD (1:500), and the
CD10IgD (germinal center) and CD10IgD (memory) B cell sub-line that was used as a positive control for lytic gene RT-PCR.
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sets were sorted. A typical separation takes up to 6 hr. All operations of a population of healthy carriers is highly skewed. However, the
natural log values of the frequencies approximate a normal distribu-were performed at 4C.
tion; therefore, most of the statistical analysis was performed using
the ln frequencies. For analysis of differences between two popula-FACS Analysis
tions, the Student’s t test was applied with the exception of analysisThe purity of all isolated populations was analyzed by flow cytometry
that included all of the spleen samples and all of the MLN samples.using a Becton Dickinson FACScaliber with CellQuest software.
In this case, the data were skewed by the large numbers of samplesWhole B cell populations were usually 
95% pure when isolated
with extremely low frequencies. For this analysis, the nonparametricwith magnetic beads (MACS or Stem Sep) and usually 
99% pure
Mann-Whitney test was also applied. Student’s t test and Mann-when isolated by FACS. IgD and IgD populations were
Whitney analysis yielded comparable results. Due to the fact thatalways 
90% and usually 
95% pure when isolated by MACS (see
we designed the experiment to consist of a two-part comparisonJoseph et al., 2000a for representative FACS analysis) and were
(tonsil versus spleen and tonsil versus MLN), we made the Bonferronialways 
95% pure and often 
99% pure when isolated by FACS
correction and took P values of less than 0.025 (rather than 0.05)(see Joseph et al., 2000b for representative FACS analysis). Memory
as statistically significant.cells (IgD, CD10, CD3, CD19) and germinal center cells (IgD,
CD10, CD3, CD19) were 90%–95% pure for the defining markers
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